ARCHIVED - 2008-09 - Main Estimates

•  
• Table of Contents
•  

This page has been archived.

Health

Department
Assisted Human Reproduction Agency of Canada
Canadian Institutes of Health Research
Hazardous Materials Information Review Commission
Patented Medicine Prices Review Board
Public Health Agency of Canada

---

Ministry Summary

Vote	(thousands of dollars)	2008-2009	2007-2008	Difference
		Main Estimates	Main Estimates
	Health
	Department
1	Operating expenditures	1,661,621	1,690,951	(29,329)
5	Capital expenditures	60,000	. . . . .	60,000
10	Grants and contributions	1,358,089	1,225,859	132,229
(S)	Contributions to employee benefit plans	110,949	111,378	(429)
(S)	Minister of Health - Salary and motor car allowance	76	75	2
	Total Department	3,190,735	3,028,263	162,472
	Assisted Human Reproduction Agency of Canada
15	Program expenditures	11,783	12,834	(1,051)
(S)	Contributions to employee benefit plans	635	642	(7)
	Total Agency	12,418	13,476	(1,058)
	Canadian Institutes of Health Research
20	Operating expenditures	42,891	42,439	452
25	Grants	881,250	822,476	58,774
(S)	Contributions to employee benefit plans	4,428	4,606	(178)
	Total Agency	928,569	869,521	59,048
	Hazardous Materials Information Review
	Commission
30	Program expenditures	3,097	3,024	73
(S)	Contributions to employee benefit plans	468	482	(14)
	Total Agency	3,565	3,506	59
	Patented Medicine Prices Review Board
35	Program expenditures	5,211	10,584	(5,373)
(S)	Contributions to employee benefit plans	631	891	(260)
	Total Agency	5,842	11,475	(5,633)
	Public Health Agency of Canada
40	Operating expenditures	360,479	438,390	(77,911)
45	Grants and contributions	199,617	189,271	10,346
(S)	Contributions to employee benefit plans	30,434	30,681	(247)
	Total Agency	590,530	658,342	(67,812)
Note: Details in the “Ministry Summary” and “Program by Activities” tables may not add to totals due to rounding.

---

Department

Strategic Outcome

Accessible and sustainable health system responsive to the health needs of Canadians.

Program Activity Descriptions

Canadian Health System

This program activity provides strategic policy advice on health care issues such as improved access, quality and integration of health care services to better meet the health needs of Canadians wherever they live or whatever their financial circumstances. The objective is pursued mindful of long-term equity, sustainability and affordability considerations and in close collaboration with provinces and territories, health professionals, administrators, other key stakeholders and citizens. Improved access, quality and integration of health services administration is achieved through investments in the health system and in health system renewal, for instance by reducing wait times for essential services, by working with provinces and territories to ensure that the principles of the Canada Health Act are respected, by developing health information and health measures for Canadians, by meeting the health and health access needs of specific groups such as women and official language minority communities, and by ensuring the implementation of agreements between federal/provincial/territorial Ministers of Health.

Canadian Assisted Human Reproduction

This program activity implements the Assisted Human Reproduction (AHR) Act , whose objective is to protect and promote human health, safety, dignity and human rights in the use of AHR technologies. It develops policies and regulations in the area of assisted human reproduction. The science of AHR evolves rapidly and, as a result, the program activity engages stakeholders on an ongoing basis to find a balance between the needs of patients who use these technologies to help them build their families, the children born from these technologies and the providers of these services with health and safety as the overriding factors. The goal of the policies and regulations is developing a responsive regulatory regime which is a leader both domestically and in the international AHR community, and reflects the objectives put forward in the AHR Act. The program activity gathers input from stakeholders, including the provinces, to ensure a pan-Canadian approach.

International Health Affairs

Health Canada works internationally through leadership, partnerships and collaboration to fulfill its federal mandate of striving to make Canada's population among the healthiest in the world. International Affairs serves as the department's focal point to initiate, coordinate, and monitor departmental policies, strategies and activities that help promote Canadian priorities and values on the international health agenda. International collaboration on global health issues is important given that the health of Canadians is influenced significantly by public health risks originating from other countries. Global issues such as pandemic influenza preparedness, HIV/AIDS strategies and global health security are critical initiatives that are discussed with key external health partners such as the World Health Organization (WHO) and the Pan American Health Organization (PAHO).

Countries and international organizations want to connect quickly to information about Canada's health care system and initiatives. The international affairs program activity strives to share Canada's best policies and practices with other countries, and assists in the development of bilateral agreements with numerous countries on important health issues. This program activity delivers strategic policy advice on international health issues to the Minister of Health, senior management and the Health Portfolio, including appropriate representation at international fora concerning the health portfolio. It also manages grants to non-profit organizations for projects in the domain of international health that are aligned with Canada's priorities in global health.

Strategic Outcome

Access to safe and effective health products and food and information for healthy choices.

Program Activity Descriptions

Health Products

The Health Products program activity is responsible for a broad range of health protection and promotion activities that affect the everyday lives of Canadians. As the federal authority responsible for the regulation of health products, the program activity evaluates and monitors the safety, quality and effectiveness of drugs (human and animal), biologics, medical devices, and natural health products, under the authority of the Food and Drugs Act and Regulations, as well as the Department of Health Act. The program activity also provides timely, evidence-based and authoritative information to key stakeholders (including but not limited to: health care professionals such as physicians, pharmacists and practitioners such as herbalists, naturopathic doctors, Traditional Chinese Medicine (TCM) practitioners) and members of the public to enable them to make informed decisions and healthy choices.

Food and Nutrition

The Food and Nutrition program activity establishes policies, regulations and standards related to the safety and nutritional quality of food. Food safety standards-quality are enforced by the Canadian Food Inspection Agency (CFIA). The legislative framework for food is found in the Food and Drugs Act and Regulations, the Canadian Food Inspection Agency Act and the Department of Health Act. The program activity also promotes the nutritional health and well-being of Canadians by collaboratively defining, promoting and implementing evidence-based nutrition policies and standards. As the focal point and authoritative source for nutrition and healthy eating policy and promotion, the program activity disseminates timely, evidence-based and authoritative information to Canadians and stakeholders to enable them to make informed decisions and healthy choices.

Strategic Outcome

Reduced Health and Environmental Risks from Products and Substances, and Healthy, Sustainable Living and Working Environments.

Program Activity Descriptions

Sustainable Environmental Health

The environment continues to be a key determinant of health for all Canadians. This program activity promotes and protects the health of Canadians by identifying, assessing and managing health risks posed by environmental factors in living, working and recreational environments. The scope of activities includes: research on drinking water quality, air quality, contaminated sites, toxicology and climate change; clean air programming and regulatory activities; risk assessment and management of: chemical substances, environmental noise, environmental electromagnetic frequencies, products of biotechnology and products of other new and emerging technologies (including nanotechnology); solar ultraviolet radiation; preparedness for nuclear and environmental disasters as well as working with the passenger conveyance industry to protect the travelling public.

Under the Chemical Management Plan, Health Canada assesses and regulates chemicals used in industrial and consumer products. Other activities include: implementing a national bio-monitoring system; developing risk management performance agreements with industry sectors; and, strengthening the assessment and management of risks to human health posed by pharmaceuticals, personal care and consumer products, cosmetics and food. Finally, enhanced communications and outreach activities allow Canadians to make better informed decisions about limiting their exposure to potential environmental hazards. Relevant Act includes the Canadian Environmental Protection Act.

Consumer Products

Health Canada identifies, assesses, manages and communicates to Canadians the health and safety risks associated with consumer products (including domestic, industrial and clinical use products), cosmetics and radiation emitting devices. This is achieved through research, risk assessments and the development of risk management strategies to minimize the exposure of Canadians to potentially hazardous products. Also included are regulatory monitoring and compliance activities as well as information, education and guidance aimed at both industry and the public. Relevant acts include: consumer products ( Hazardous Products Act) , cosmetics ( Food and Drugs Act) and radiation emitting devices ( Radiation Emitting Devices Act).

Workplace Health

This program activity provides services to protect the health and safety of the federal public sector, visiting dignitaries, and others. Specific programs include: the provision of occupational health services to federal employees; delivery of the Employee Assistance Program; emergency health services to Internationally Protected Persons; dosimetry services (the measurement of personal, occupational exposure to radiation through the reading of “dosimeters” or plaques enclosed in special holders worn by the user for specified periods); and, Workplace Hazardous Materials Information System (WHMIS) a national hazard communication standard, including worker education, inspector training, and standards for cautionary labels.

Substance Use and Abuse

Through regulatory, programming and educational activities, Health Canada seeks to improve health outcomes by reducing and preventing tobacco consumption and combatting alcohol and drug abuse. Through the Tobacco Act and its regulations, Health Canada regulates aspects of the manufacture and sale of tobacco. It also leads the Federal Tobacco Control Strategy -the goals of which are to: further reduce the prevalence of smoking; decrease the number of cigarettes sold; increase compliance with sales-to-youth laws; reduce exposure to second hand smoke; and, continue to explore ways to regulate the product.

Health Canada administers the Controlled Drugs and Substances Act (CDSA) and its regulations. Through four regional labs, Health Canada provides expert scientific advice and drug analysis services to law enforcement agencies. The Marihuana Medical Access Regulations and related programs control the authorization for use and cultivation of marihuana by those suffering from grave and debilitating illnesses. Health Canada is a partner in the government's anti-drug strategy which includes: prevention programming aimed at youth; facilitating access to treatment programs; compliance and enforcement activities related to controlled substances and precursor chemicals; and, increased resources to Drug Analysis Services commensurate with the increase in law enforcement resources.

Pesticide Regulation

To help prevent unacceptable risks to people and the environment, and facilitate access to sustainable pest management tools, Health Canada, through the Pest Management Regulatory Agency, regulates the importation, sale and use of pesticides under the federal authority of the Pest Control Products Act (PCPA) and Regulations.

Strategic Outcome

Better health outcomes and reduction of health inequalities between First Nations and Inuit and other Canadians.

Program Activity Descriptions

First Nations and Inuit Health Programming and Services

The provision of health programs and services by Health Canada to First Nations and Inuit is rooted in the Federal Indian Health Policy. The Department provides health programs and services to First Nations and Inuit as a matter of policy, using the Annual Appropriations Act to obtain Parliamentary approval. Together with First Nations and Inuit and other health partners, the First Nations and Inuit Health Branch through it's regional offices, delivers public health and community health programs on-reserve, these include environmental health and communicable and non-communicable disease prevention, and provision of primary health care services through nursing stations and community health centres in remote and/or isolated communities to supplement and support the services that provincial, territorial and regional health authorities provide. We also support targeted health promotion programs for Aboriginal people, regardless of residency (e.g. Aboriginal Diabetes Initiative) as well as counselling, addictions and mental wellness services. The Non-Insured Health Benefits coverage of drug, dental care, vision care, medical supplies and equipment, short-term crisis intervention mental health services, and medical transportation is available to all registered Indians and recognized Inuit in Canada, regardless of residency.

Program by Activities
(thousands of dollars)			2008-2009 Main Estimates				2007-2008
			Budgetary			Total	Main
	Operating	Capital	Grants	Contributions	Less:		Estimates
				and other	Revenues
				transfer	credited
				payments	to the vote
First Nations and Inuit Health Programming
and Services	1,115,617	18,165	30,000	997,301	5,450	2,155,633	. . . . .
Canadian Health System	47,034	820	182,446	75,896	. . . . .	306,196	. . . . .
Health Products	198,000	15,235	5,900	4,000	39,863	183,272	. . . . .
Sustainable Environmental Health	156,111	10,740	605	. . . . .	1,400	166,056	. . . . .
Substance Use and Abuse	87,944	4,733	4,250	55,816	. . . . .	152,743	. . . . .
Food and Nutrition	71,884	7,105	. . . . .	. . . . .	1,343	77,646	. . . . .
Pesticide Regulation	65,626	1,645	. . . . .	. . . . .	6,975	60,296	. . . . .
Workplace Health	47,431	877	. . . . .	. . . . .	14,140	34,168	. . . . .
International Health Affairs	26,716	. . . . .	1,875	. . . . .	. . . . .	28,591	. . . . .
Consumer Products	23,875	680	. . . . .	. . . . .	454	24,101	. . . . .
Canadian Assisted Human Reproduction	2,033	. . . . .	. . . . .	. . . . .	. . . . .	2,033	. . . . .
First Nations and Inuit Health	. . . . .	. . . . .	. . . . .	. . . . .	. . . . .	. . . . .	2,123,076
Healthy Environments and Consumer
Safety	. . . . .	. . . . .	. . . . .	. . . . .	. . . . .	. . . . .	333,487
Health Policy, Planning and Information	. . . . .	. . . . .	. . . . .	. . . . .	. . . . .	. . . . .	263,685
Health Products and Food	. . . . .	. . . . .	. . . . .	. . . . .	. . . . .	. . . . .	257,164
Pest Control Product Regulation	. . . . .	. . . . .	. . . . .	. . . . .	. . . . .	. . . . .	50,852
	1,842,271	60,000	225,076	1,133,013	69,625	3,190,735	3,028,263

Transfer Payments

(dollars)	2008-2009	2007-2008
	Main Estimates	Main Estimates
Grants
Grant to the Canadian Institute for Health Information	81,746,000	24,720,000
Grant to the Canadian Partnership Against Cancer	58,200,000	50,000,000
Grant to the Canadian Agency for Drugs and Technologies in Health	16,903,967	17,403,967
Nunavut Medical Travel Fund	10,200,000	10,200,000
Grant to the Health Council of Canada	10,000,000	10,000,000
Grant to the Canadian Patient Safety Institute	8,000,000	8,000,000
Grant to support the Mental Health Commission of Canada	7,500,000	. . . . .
Grant to the Government of Yukon for the Territorial Health Access
Fund and Operational Secretariat	6,333,333	6,333,334
Grant to the Canadian Blood Services : Blood Safety and Effectiveness
and Research and Development	5,000,000	5,000,000
Grant to the Government of Nunavut for the Territorial Health Access
Fund	4,333,334	4,333,333
Grant to the Government of Northwest Territories for the Territorial
Health Access Fund	4,333,333	4,333,333
Grant to the Canadian Centre on Substance Abuse	3,750,000	3,750,000
Northwest Territories Medical Travel Fund	3,200,000	3,200,000
Grant to eligible non-profit international organizations in support of
their projects or programs on health	2,475,000	2,135,000
Yukon Medical Travel Fund	1,600,000	1,600,000
Health Canada Post-Doctoral Fellowship Program	1,000,000	1,000,000
Natural Health Products Research Grant	400,000	400,000
Health Care Strategies and Policy, Federal/Provincial/Territorial
Partnership Grant Program	96,033	96,033
International Commission on Radiological Protection	5,000	5,000
Total grants	225,076,000	152,510,000
Contributions
Contributions for First Nations and Inuit Community Programs	236,502,522	219,913,539
First Nations and Inuit Health Services Transfer	233,853,383	. . . . .
Contributions for First Nations and Inuit Health Governance and
Infrastructure Support	191,527,870	185,313,328
Contributions for First Nations and Inuit Health Benefits	135,444,527	131,862,740
Contributions for First Nations and Inuit Primary Health Care	122,152,934	121,197,000
Health Care Strategies and Policy Contribution Program	50,046,000	37,356,240
Contributions for First Nations and Inuit Health Facilities and Capital
Program	46,512,678	51,275,042
Drug Treatment Funding Program	26,752,109	. . . . .
Contributions Program to improve access to health services for official
language minority communities	23,000,000	23,000,000
Contributions in support of the Federal Tobacco Control Strategy	15,759,000	15,759,000
Drug Strategy Community Initiatives Fund	13,304,891	11,832,588
Contributions for First Nations and Inuit Health Protection	10,285,281	12,169,441
Contributions for Bigstone Non-Insured Health Benefits Pilot Project	8,821,805	8,487,200
Contributions for the Indian Residential Schools Resolution Health
Support Program	7,200,000	. . . . .
Contribution to the Organization for the Advancement of Aboriginal
People's Health	5,000,000	5,000,000
Contribution to strengthen Canada's organs and tissues donation and
transplantation system	3,600,000	3,600,000
Women's Health Contributions Program	2,850,000	2,850,000
Natural Health Products Research Contribution	400,000	400,000
Total contributions	1,133,013,000	830,016,118
Items not required
Payments to Indian bands, associations or groups for the control and
provision of health services	. . . . .	227,903,381
Payments to provinces and territories to assist in ensuring access for
Canadians to effective alcohol and drug treatment and rehabilitation
programs and services	. . . . .	13,200,000
Contribution to the Canadian Institute for Health Information	. . . . .	2,230,000
Total items not required	. . . . .	243,333,381
Total	1,358,089,000	1,225,859,499

---

Assisted Human Reproduction Agency of Canada

Strategic Outcome

Protection and promotion of the health and safety of Canadians against the risks associated with assisted human reproduction technologies.

Program Activity Descriptions

Licencing and Enforcement of a Regulatory Framework for Assisted Human Reproduction Technologies

The Assisted Human Reproduction Agency of Canada would achieve this objective by the following means: issuing licences for controlled activities and for facilities used by qualified persons or organizations; assessing applications against licence requirements, including scientific and ethical considerations; conducting periodic inspections of assisted human reproduction clinics, service providers or research to ensure compliance; and enlisting the participation or support of other recognized organizations in the development of other supporting policy instruments, for example, standards, guidelines and accreditation models.

Health Information and Knowledge Management for Assisted Human Reproduction Technologies

The Assisted Human Reproduction Agency of Canada would achieve this objective by the following means: maintaining a personal health information registry to consolidate health reporting information concerning donors, patients and offspring born of assisted human reproduction procedures to allow for a look-back and trace-back mechanism; providing ongoing reports of assisted human reproduction controlled activities, including success rates by assisted human reproduction clinics and results of research, to enable prospective assisted human reproduction users to make informed decisions; and providing public information on assisted human reproduction matters or issues via a public website or in other forms such as brochures.

Program by Activities
(thousands of dollars)	2008-2009 Main Estimates 2007-2008
	Budgetary	Total	Main
	Operating		Estimates
Licencing and Enforcement of a Regulatory Framework
for Assisted Human Reproduction Technologies	7,804	7,804	6,076
Health Information and Knowledge Management for
Assisted Human Reproduction Technologies	4,614	4,614	7,400
	12,418	12,418	13,476

---

Canadian Institutes of Health Research

Strategic Outcome

Canadian health research advances health knowledge and is responsive to current opportunities and priorities.

Program Activity Descriptions

Open Research

Enabling the conduct of health research in emerging areas of science across all disciplines that are relevant to health. This is achieved through managing and launching competitions, based on internationally accepted standards of scientific excellence and a peer review process, to fund grants open to all areas of health research.

Strategic Priority Research

Enabling the conduct of health research to address strategic health opportunities, threats and challenges to Canadians, identified in consultation with health research partners and aligned with government priorities. This is achieved through managing and launching competitions to fund grants in targeted priority health research areas.

Strategic Outcome

A strong and talented health research community with the capacity to undertake health research.

Program Activity Descriptions

Researchers and Trainees

Building the capacity of the Canadian health research community by providing the next generation of multidisciplinary health researchers with training and development support, and providing highly-qualified health researchers with sustained support for scientific careers in health research. This is achieved through managing competitions and programs to fund salary and training awards for health researchers and trainees.

Research Resources and Collaboration

Strengthening the health research community's ability to conduct research by supporting research-enabling activities and resources. This includes: supporting large teams of researchers from across disciplines in resolving some of the most complex health problems facing Canadians; engaging in collaborative activities such as networking between researchers; and providing and maintaining state-of-the-art tools to conduct research such as new equipment, databases and other specialized resources. This is achieved through managing and launching competitions and programs to fund grants that give researchers the resources to better undertake their research.

National and International Partnerships

Developing strong national and international partnerships, through CIHR's thirteen Institutes, to advance strategic health research priorities, and leverage funding and expertise for research. These partners include health policy-makers at provincial and federal levels of government, the private sector, and voluntary health organizations from Canada and abroad. This is achieved through funding grants to support Institute activities, and managing competitions to fund partnered research projects and the participation of Canadian scientists in international research collaborations.

Ethical, Legal and Social Issues

Enabling the conduct of research on ethical, legal and social issues pertaining to health and health research, and the application of ethical principles to health research. This is achieved through managing competitions to fund grants for research on health-related ethical, legal and social issues, and conducting consultations to enable dialogue and greater public engagement.

Strategic Outcome

Health research is translated and adopted into practice, programs and policies that offer more effective health services and products, a strengthened health care system, and the improved health of Canadians.

Program Activity Descriptions

Knowledge Translation of Health Research

Enabling the effective dissemination and exchange of health research knowledge, and the application of health research results discoveries to lead to improvements in the Canadian health system and overall health of Canadians. This is achieved through managing competitions and programs to fund grants for translating health research discoveries into new or more effective health policy or practice, and for building increased knowledge translation capacity in Canada's health research community.

Commercialization of Health Research

Encouraging innovation and facilitating the commercialization of health research in Canada into new health products and services. This is achieved through managing competitions to fund grants for supporting the commercialization of health research, in partnership with the private sector, and for building increased commercialization capacity in Canada's health research community.

Program by Activities
(thousands of dollars)	2008-2009 Main Estimates			2007-2008
	Budgetary		Total	Main
	Operating	Grants		Estimates
Open Research	23,132	439,500	462,632	. . . . .
Researchers and Trainees	10,278	185,817	196,095	203,589
Strategic Priority Research	6,236	116,371	122,607	. . . . .
Research Resources and Collaboration	2,535	48,315	50,850	69,959
Knowledge Translation of Health Research	1,946	38,828	40,774	40,746
Commercialization of Health Research	1,317	26,192	27,509	27,281
National and International Partnerships	1,442	23,728	25,170	28,083
Ethical, Legal and Social Issues	432	2,499	2,931	6,314
Fund health research	. . . . .	. . . . .	. . . . .	493,549
	47,319	881,250	928,569	869,521

Transfer Payments

(dollars)	2008-2009	2007-2008
	Main Estimates	Main Estimates
Grants
Grants for research projects and personnel support	849,370,000	798,976,000
Canada Graduate Scholarships	18,880,000	10,500,000
Institute support grants	13,000,000	13,000,000
Total	881,250,000	822,476,000

---

Hazardous Materials Information Review Commission

Strategic Outcome

Trade secret exemptions are provided in a way that balances the right of industry to protect their confidential business information with the right of workers to receive accurate information concerning the health and safety hazards posed by chemicals in the workplace.

Program Activity Descriptions

Claims Exemption Process

Under this activity, the Hazardous Materials Information Review Commission registers claims for exemption received from a supplier or employer who wishes to withhold confidential business information, decides on the validity of the claim, adjudicates and issues decisions on the compliance of the material safety data sheet (MSDS) or label to which the claim relates, and administers an appeal process to these decisions.

Program by Activities
(thousands of dollars)	2008-2009 Main Estimates 2007-2008
	Budgetary	Total	Main
	Operating		Estimates
Claims Exemption Process	3,565	3,565	3,506
	3,565	3,565	3,506

---

Patented Medicine Prices Review Board

Strategic Outcome

Canadians and their health care system are protected from excessive pricing for patented medicines sold in Canada and are informed on pharmaceutical trends.

Program Activity Descriptions

Pharmaceutical trends

Through this program activity, the Patented Medicine Prices Review Board (PMPRB) provides analysis of pharmaceutical price trends and research and development spending by pharmaceutical patentees. It also provides critical analyses of price, utilization and cost trends for prescription drugs, and information on non-patented prescription drug prices. The PMPRB reports on this information and its price review and enforcement activities as they relate to excessive pricing for patented medicines, both annually to Parliament, through the Minister of Health, and through special published studies.

Compliance and enforcement of non-excessive pricing for patented medicines

The PMPRB is responsible for regulating the prices that patentees charge for patented drugs sold in Canada to wholesalers, hospitals, pharmacies or others, for human and veterinary use. Through this program activity, the PMPRB reviews the prices that patentees charge for patented drugs, based on the price review factors in the Patent Act , to ensure that these prices are not excessive. In the event that the Board finds, following a public hearing, that a price is excessive in any market, it may order the patentee to reduce the price and take measures to offset any excess revenues it may have received as a result of excessive prices.

Program by Activities
(thousands of dollars)	2008-2009 Main Estimates 2007-2008
	Budgetary	Total	Main
	Operating		Estimates
Compliance and enforcement of non-excessive pricing for
patented medicines	3,194	3,194	. . . . .
Pharmaceutical trends	2,648	2,648	. . . . .
Patented Medicine Prices Review	. . . . .	. . . . .	11,475
	5,842	5,842	11,475

---

Public Health Agency of Canada

Strategic Outcome

Healthier Canadians, reduced health disparities, and a stronger public health capacity.

Program Activity Descriptions

Health Promotion

In collaboration with partners, the Public Health Agency of Canada supports effective actions to promote healthy living, build healthy communities and address the key determinants of health and major risk factors for chronic disease, by contributing to knowledge development, fostering collaboration, and improving information exchange among sectors and across jurisdictions.

Chronic Disease Prevention and Control

Working in cooperation with regional, provincial/territorial, national and international governments and stakeholders (including non-governmental organizations), the program provides national population health assessment and surveillance in relation to chronic diseases. It also provides and supports leadership and expertise in the development and implementation of pan-Canadian chronic disease prevention, control and management strategies. This program is necessary because chronic diseases are among the most common, preventable and costly health problems facing Canadians.

Infectious Disease Prevention and Control

The program promotes improved health for Canadians in the area of infectious diseases through public health actions including surveillance and epidemiology, risk management, public health policy development, and prevention and care programs. This program is necessary as infectious diseases require national attention and national efforts given their current and potential impact on the health of Canadians and the Canadian health care system, and also because new, existing, or re-emerging infectious diseases can pose a serious threat to the health and socio-economic well-being of Canadians.

Emergency Preparedness and Response

The Agency is a national focal point for anticipating, preparing for, responding to and facilitating recovery from public health consequences of natural disasters or human caused emergencies. The program applies the legislative and regulatory provisions of The Quarantine Act . Partnering with Health Canada, other federal departments, the provinces and territories, international organizations and the voluntary sector, the Agency provides leadership in addressing emerging threats through surveillance, risk analysis, and risk management; and implements preparedness priorities. The program manages and supports the development of health-related emergency response plans, including the National Influenza Response Plan. It develops and sponsors emergency preparedness training, and coordinates counter-terrorism preparations for incidents involving hazardous substances. It provides emergency health and social services, and manages the National Emergency Stockpile System.

Strengthen Public Health Capacity

Working with national and international partners, the Agency develops and provides tools, applications, practices, programs and understandings that support and develop the capabilities of front-line public health practitioners across Canada. The Agency facilitates and sustains networks with provinces, territories, and other partners and stakeholders to achieve public health objectives. The Agency's work improves public health practice, increases cross-jurisdictional human resources capacity, contributes to effective knowledge and information systems, and supports a public health law and policy system that evolves in response to changes in public needs and expectations.

Program by Activities

(thousands of dollars)		2008-2009 Main Estimates				2007-2008
		Budgetary			Total	Main
	Operating	Grants	Contributions	Less:		Estimates
			and other	Revenues
			transfer	credited
			payments	to the vote
Infectious Disease Prevention and Control	203,480	8,595	22,843	. . . . .	234,918	. . . . .
Health Promotion	70,095	11,670	121,798	. . . . .	203,563	186,418
Chronic Disease Prevention and Control	44,769	11,795	12,396	. . . . .	68,960	300,469
Strengthen Public Health Capacity	33,600	1,094	9,426	. . . . .	44,120	55,600
Emergency Preparedness and Response	39,020	. . . . .	. . . . .	50	38,970	115,855
	390,963	33,154	166,463	50	590,530	658,342
Transfer Payments
(dollars)				2008-2009	2007-2008
			Main Estimates		Main Estimates
Grants
Grants to persons and agencies to support health promotion projects in
the areas of community health, resource development, training and
skill development and research				22,170,000	21,236,000
Grants toward the Federal Initiative on HIV/AIDS				6,565,000		8,010,000
Grant to the National Cancer Institute of Canada for the Canadian
Breast Cancer Research Initiative				3,000,000		3,000,000
Grants to graduate students and post-graduate students in public health
and university departments in community medicine and public
health				1,094,000		1,731,000
Grants to individuals and organizations in support of public health
infrastructure				325,000		125,000
Total grants				33,154,000	34,102,000
Contributions
Contributions to non-profit community organizations to support, on a
long-term basis, the development and provision of preventative and
early intervention services aimed at addressing the health and
developmental problems experienced by young children at risk in
Canada				75,088,000		75,088,000
Contributions to persons and agencies to support health promotion
projects in the areas of community health, resource development,
training and skill development and research				44,907,000		37,220,000
Contributions to incorporated local or regional non-profit Aboriginal
organizations and institutions for the purpose of developing early
intervention programs for Aboriginal pre-school children and their
families				26,651,000		26,651,000
Contribution toward the Federal Initiative on HIV/AIDS				16,439,000		12,832,000
Contributions to Canadian Blood Services and/or other designated
transfusion/transplantation centres to support adverse event
surveillance activities				2,197,000		2,197,000
Contributions to universities and public health organizations to create
public health workforce development products and tools				1,056,000		1,056,000
Contributions to individuals and organizations in support of public
health infrastructure				125,000		125,000
Total contributions				166,463,000		155,169,000
Total				199,617,000		189,271,000

•  
• Table of Contents
•